Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 40
Encontrada(s) 1 página(s)

Biblos-e Archivo. Repositorio Institucional de la UAM
Publicación Artículo científico (JournalArticle)

RUbioSeq+: A multiplatform application that executes parallelized pipelines to analyse next-generation sequencing data

  • Rubio-Camarillo, Miriam
  • López-Fernández, Hugo
This is the peer reviewed version of the following article: Computer Methods and Programs in Biomedine 138 (2016): 73-81, which has been published in final form at http://dx.doi.org/10.1016/j.cmpb.2016.10.008, Background and objective To facilitate routine analysis and to improve the reproducibility of the results, next-generation sequencing (NGS) analysis requires intuitive, efficient and integrated data processing pipelines. Methods We have selected well-established software to construct a suite of automated and parallelized workflows to analyse NGS data for DNA-seq (single-nucleotide variants (SNVs) and indels), CNA-seq, bisulfite-seq and ChIP-seq experiments. Results Here, we present RUbioSeq+, an updated and extended version of RUbioSeq, a multiplatform application that incorporates a suite of automated and parallelized workflows to analyse NGS data. This new version includes: (i) an interactive graphical user interface (GUI) that facilitates its use by both biomedical researchers and bioinformaticians, (ii) a new pipeline for ChIP-seq experiments, (iii) pair-wise comparisons (case–control analyses) for DNA-seq experiments, (iv) and improvements in the parallelized and multithreaded execution options. Results generated by our software have been experimentally validated and accepted for publication. Conclusions RUbioSeq+ is free and open to all users at http://rubioseq.bioinfo.cnio.es/., M.R-C is funded by the BLUEPRINT Consortium (FP7/ 2007-2013) under grant agreement number 282510. J.M.F is funded by the INB Node 2 - CNIO, a member of Proteored - PRB2-ISCIII and is supported by grant PT13/0001, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER. H.L-F is funded by a postdoctoral fellowship from the Xunta de Galicia. F.F-R and D.G-P are funded by the European Union's Seventh Framework Programme FP7/REGPOT 2012 2013.1 under grant agreement n° 316265 (BIOCAPS) and the "Platform of integration of intelligent techniques for analysis of biomedical information" project (TIN2013-47153-C3-3-R) financed by the Spanish Ministry of Economy and Competitiveness C.FT is funded by the "Spanish National Youth Guarantee Implementation Plan” (2013/2016) financed by the Spanish Ministry of Economy and Competitiveness
RUNA. Repositorio da Consellería de Sanidade e Sergas
Publicación Artículo científico (JournalArticle)

Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings.

  • Represas Represas, Cristina
  • Fernández Villar, José Alberto
  • Ruano Raviña, Alberto
  • Priegue Carrera, Ana
  • Botana Rial, María Isabel
The underdiagnosis of chronic obstructive pulmonary disease (COPD) could be improved through screening using portable devices simpler than conventional spirometers in specific healthcare settings to reach a higher percentage of the at-risk population. This study was designed to assess the validity and reliability of the COPD-6 portable device to screen for COPD in non-specialized healthcare settings. Prospective cohort study to validate a diagnostic test. Three cohorts were recruited: primary care (PC), emergency services (ES) and community pharmacies (CPh). individuals with risk factors for COPD (>40 years, smoking >10 pack-years, with respiratory symptoms). The values measured using the COPD-6 were FEV1, FEV6 and the FEV1/FEV6 ratio. Subsequently, participants underwent conventional spirometry at hospital, using a post-bronchodilator FEV1/FVC value <0.7 as the gold standard criterion for the COPD diagnosis. 437 participants were included, 362 were valid for the analysis. COPD was diagnosed in 114 patients (31.5%). The area under the ROC curve for the COPD-6 for COPD screening was 0.8.The best cut-off point for the FEV1/FEV6 ratio was 0.8 (sensitivity, 92.1%) using spirometry with the bronchodilator test as the gold standard. There were practically no differences in the COPD-6 performance in the different settings and also regarding age, gender and smoking status. The COPD-6 device is a valid tool for COPD screening in non-specialized healthcare settings. In this context, the best cut-off point for the FEV1/FEV6 ratio is 0.8., Fundación de la Sociedad Gallega de Patología Respiratoria (SOGAPAR), European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1] under grant agreement n° 316265, BIOCAPS
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings

  • Represas Represas, Cristina
  • Fernández Villar, Alberto
  • Ruano Raviña, Alberto
  • Priegue Carrera, Ana
  • Botana Rial, María Isabel
Introduction and Objectives The underdiagnosis of chronic obstructive pulmonary disease (COPD) could be improved through screening using portable devices simpler than conventional spirometers in specific healthcare settings to reach a higher percentage of the at-risk population. This study was designed to assess the validity and reliability of the COPD-6 portable device to screen for COPD in non-specialized healthcare settings. Methods Prospective cohort study to validate a diagnostic test. Three cohorts were recruited: primary care (PC), emergency services (ES) and community pharmacies (CPh). Study population: individuals with risk factors for COPD (>40 years, smoking >10 pack-years, with respiratory symptoms). The values measured using the COPD-6 were FEV1, FEV6 and the FEV1/FEV6 ratio. Subsequently, participants underwent conventional spirometry at hospital, using a post-bronchodilator FEV1/FVC value <0.7 as the gold standard criterion for the COPD diagnosis. Results 437 participants were included, 362 were valid for the analysis. COPD was diagnosed in 114 patients (31.5%). The area under the ROC curve for the COPD-6 for COPD screening was 0.8.The best cut-off point for the FEV1/FEV6 ratio was 0.8 (sensitivity, 92.1%) using spirometry with the bronchodilator test as the gold standard. There were practically no differences in the COPD-6 performancein the different settings and also regarding age, gender and smoking status. Conclusions The COPD-6 device is a valid tool for COPD screening in non-specialized healthcare settings. In this context, the best cut-off point for the FEV1/FEV6 ratio is 0.8
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest

  • Cordero Santamaría, Óscar Javier
  • Varela Calviño, Rubén
  • López González, Tania
  • Grujic, Milica
  • Juranic, Zorica
  • Mouriño, Coral
  • Hernández Rodríguez, Íñigo
  • Rodríguez López, Marina
  • Aspe de la Iglesia, Bruno
  • Pego Reigosa, José María
Objectives Rheumatoid arthritis (RA) patients show low serum levels of the Ag dipeptidyl peptidase IV (DPP-IV/CD26), both soluble CD26 (sCD26) concentration and its DPP-IV activity. The aim of this study was to test if anti-DPP-IV/CD26 Abs (Anti-CD26) cleared sCD26. Design & methods Serum Anti-CD26 and Total titers (as comparison) of isotypes IgA, IgM and IgG as well as sCD26 concentration and DPP-IV activity were measured in a cohort of RA patients undergoing different biological and non-biological therapies (n = 105) and controls (n = 50). Results Anti-CD26 levels were increased approximately two-fold for each isotype in RA, were not related to the sCD26 clearance, showed several correlations with disease activity parameters, were significantly higher in smokers and they were not ACPA. Anti-CD26 Igs showed high diagnostic power (82% sensitivity and 96% specificity) and their levels differed amongst the different groups of patients stratified by the type of therapy. Conclusions As DPP-IV/CD26 is associated to factors triggering RA in the lung and periodontal tissue, these results suggest that Anti-CD26 isotypes may participate in pathogenesis and may be useful as biomarkers for earlier diagnosis and/or precision medicine
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis

  • Cordero Santamaría, Óscar Javier
  • Varela Calviño, Rubén
  • López González, Tania
  • Calviño Sampedro, Cristina
  • Viñuela Roldán, Juan Evaristo
  • Mouriño Rodríguez, Coral
  • Hernández Rodríguez, Íñigo
  • Rodríguez López, Marina
  • Aspe de la Iglesia, Bruno
  • Pego Reigosa, José María
We studied dipeptidyl peptidase IV (DPP-IV, CD26) expression in different T helper cells and serum soluble DPP-IV/sCD26 levels in rheumatoid arthritis (RA) patients, correlated these with disease activity score (DAS), and examined how they were affected by different therapies, conventional or biological (anti-TNF, anti-CD20 and anti-IL6R or Ig-CTLA4). The percentage of CD4+CD45R0+CD26- cells was greatly reduced in patients (up to 50%) when compared with healthy subjects. Three other subsets of CD4 cells, including a CD26high Th1-associated population, changed variably with therapies. Data from these subsets (frequency and staining density) significantly correlated with DAS28 or DAS28 components but different in each group of patients undergoing the different therapies. Th17 and Th22 subsets were implicated in RA as independent CCR4+ and CCR4- populations each, with distinct CD26 expression, and were targeted with varying efficiency by each therapy. Serum DPP-IV activity rather than sCD26 levels was lower in RA patients compared to healthy donors. DPP-IV and sCD26 serum levels were found related to specific T cell subsets but not to disease activity. We conclude that, according to their CD26 expression, different cell subsets could serve to monitor RA course, and an uncharacterized T helper CD26- subset, not targeted by therapies, should be monitored for early diagnosis
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

In situ nanofabrication of hybrid PEG-dendritic–inorganic nanoparticles and preliminary evaluation of their biocompatibility

  • Sousa Hervés, Ana
  • Sánchez Espinel, Christian
  • Fahmi, Amir
  • González-Fernández, África
  • Fernández Megía, Eduardo
An in situ template fabrication of inorganic nanoparticles using carboxylated PEG-dendritic block copolymers of the GATG family is described as a function of the dendritic block generation, the metal (Au, CdSe) and metal molar ratio. The biocompatibility of the generated nanoparticles analysed in terms of their aggregation in physiological media, cytotoxicity and uptake by macrophages relates to the PEG density of the surface of the hybrids
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers

  • Hidalgo, T.
  • Giménez Marqués, M.
  • Bellido, E.
  • Avila, J.
  • Asensio, M.C.
  • Salles, F.
  • Lozano, M.V.
  • Guillevic, M.
  • Simón Vázquez, Rosana
  • González Fernández, África
  • Serre, C.
  • Alonso Fernández, María José
  • Horcajada, P.
Nanometric biocompatible Metal-Organic Frameworks (nanoMOFs) are promising candidates for drug delivery. Up to now, most studies have targeted the intravenous route, related to pain and severe complications; whereas nanoMOFs for oral administration, a commonly used non-invasive and simpler route, remains however unexplored. We propose here the biofriendly preparation of a suitable oral nanocarrier based on the benchmarked biocompatible mesoporous iron(III) trimesate nanoparticles coated with the bioadhesive polysaccharide chitosan (CS). This method does not hamper the textural/structural properties and the sorption/release abilities of the nanoMOFs upon surface engineering. The interaction between the CS and the nanoparticles has been characterized through a combination of high resolution soft X-ray absorption and computing simulation, while the positive impact of the coating on the colloidal and chemical stability under oral simulated conditions is here demonstrated. Finally, the intestinal barrier bypass capability and biocompatibility of CS-coated nanoMOF have been assessed in vitro, leading to an increased intestinal permeability with respect to the non-coated material, maintaining an optimal biocompatibility. In conclusion, the preservation of the interesting physicochemical features of the CS-coated nanoMOF and their adapted colloidal stability and progressive biodegradation, together with their improved intestinal barrier bypass, make these nanoparticles a promising oral nanocarrier
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Characterization of a monoclonal antibody directed against mytilus spp larvae reveals an antigen involved in shell biomineralization

  • Calvo-Iglesias, Juan
  • Pérez-Estévez, Daniel
  • Lorenzo-Abalde, Silvia
  • Sánchez Correa, Beatriz
  • Quiroga Berdeal, María Isabel
  • Fuentes, José M.
  • González Fernández, África
The M22.8 monoclonal antibody (mAb) developed against an antigen expressed at the mussel larval and postlarval stages of Mytilus galloprovincialis was studied on adult samples. Antigenic characterization by Western blot showed that the antigen MSP22.8 has a restricted distribution that includes mantle edge tissue, extrapallial fluid, extrapallial fluid hemocytes, and the shell organic matrix of adult samples. Other tissues such as central mantle, gonadal tissue, digestive gland, labial palps, foot, and byssal retractor muscle did not express the antigen. Immunohistochemistry assays identified MSP22.8 in cells located in the outer fold epithelium of the mantle edge up to the pallial line. Flow cytometry analysis showed that hemocytes from the extrapallial fluid also contain the antigen intracellularly. Furthermore, hemocytes from hemolymph have the ability to internalize the antigen when exposed to a cell-free extrapallial fluid solution. Our findings indicate that hemocytes could play an important role in the biomineralization process and, as a consequence, they have been included in a model of shell formation. This is the first report concerning a protein secreted by the mantle edge into the extrapallial space and how it becomes part of the shell matrix framework in M. galloprovincialis mussels.
Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

Human Early Life Exposome (HELIX) study: a European population-based exposome cohort

  • Maitre, Léa
  • De Bont, Jeroen
  • Casas, Maribel
  • Robinson, Oliver
  • Aasvang, Gunn Marit
  • Agier, Lydiane
  • Andrušaitytė, Sandra
  • Ballester, Ferrán
  • Basagaña, Xavier
  • Borràs, Eva
  • Brochot, Céline
  • Bustamante, Mariona
  • Carracedo, Angel
  • De Castro, Montserrat
  • Dedele, Audrius
  • De Castro, Montserrat
  • Dedele, Audrius
  • Donaire González, David
  • Estivill, Xavier
  • Evandt, Jorunn
  • Fossati, Serena
  • Giorgis Allemand, Lise
  • Granum, Berit
  • Grazuleviciene, Regina
  • Gützkow, Kristine Bjerve
  • Småstuen Haug, Line
  • Hernández Ferrer, Carles
  • Heude, Barbara
  • Ibarluzea Maurolagoitia, Jesús María
  • Julvez, Jordi
  • Karachaliou, Marianna
  • Keun, Hector C
  • Hjertager Krog, Norun
  • Lau, Chung-Ho E.
  • Leventakou, Vasiliki
  • Lyon Caen, Sarah
  • Manzano, Cyntia
  • Mason, Dan
  • McEachan, Rosemary
  • Meltzer, Helle Margrete
  • Petraviciene, Inga
  • Quentin, Joane
  • Roumeliotaki, Theano
  • Sabidó, Eduard
  • Saulnier, Pierre-Jean
  • Siskos, Alexandros P
  • Siroux, Valérie
  • Sunyer, Jordi
  • Tamayo, Ibon
  • Urquiza, Jose
  • Vafeiadi, Marina
  • Van Gent, Diana
  • Vives Usano, Marta
  • Waiblinger, Dagmar
  • Warembourg, Charline
  • Chatzi, Leda
  • Coen, Muireann
  • Van den Hazel, Peter
  • Nieuwenhuijsen, Mark J.
  • Slama, Rémy
  • Thomsen, Cathrine
  • Wright, John
  • Vrijheid, Martine
Purpose Essential to exposome research is the collection of data on many environmental exposures from different domains in the same subjects. The aim of the Human Early Life Exposome (HELIX) study was to measure and describe multiple environmental exposures during early life (pregnancy and childhood) in a prospective cohort and associate these exposures with molecular omics signatures and child health outcomes. Here, we describe recruitment, measurements available and baseline data of the HELIX study populations. Participants The HELIX study represents a collaborative project across six established and ongoing longitudinal population-based birth cohort studies in six European countries (France, Greece, Lithuania, Norway, Spain and the UK). HELIX used a multilevel study design with the entire study population totalling 31472 mother-child pairs, recruited during pregnancy, in the six existing cohorts (first level); a subcohort of 1301 mother-child pairs where biomarkers, omics signatures and child health outcomes were measured at age 6-11 years (second level) and repeat-sampling panel studies with around 150 children and 150 pregnant women aimed at collecting personal exposure data (third level). Findings to date Cohort data include urban environment, hazardous substances and lifestyle-related exposures for women during pregnancy and their offspring from birth until 6-11 years. Common, standardised protocols were used to collect biological samples, measure exposure biomarkers and omics signatures and assess child health across the six cohorts. Baseline data of the cohort show substantial variation in health outcomes and determinants between the six countries, for example, in family affluence levels, tobacco smoking, physical activity, dietary habits and prevalence of childhood obesity, asthma, allergies and attention deficit hyperactivity disorder. Future plans HELIX study results will inform on the early life exposome and its association with molecular omics signatures and child health outcomes. Cohort data are accessible for future research involving researchers external to the project., The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-206) under grant agreement no 308333-the HELIX project. Dr Maribel Casas and Dr Jordi Julvez received funding from Instituto de Salud Carlos III (Ministry of Economy and Competitiveness) (MS16/00128, MS14/00108). INMA data collections were supported by grants from the Instituto de Salud Carlos III, CIBERESP, the Conselleria de Sanitat, Generalitat Valenciana, Department of Health of the Basque Government; the Provincial Government of Gipuzkoa, and the Generalitat de Catalunya-CIRIT. KANC was funded by the grant of the Lithuanian Agency for Science Innovation and Technology (6-04-2014_31V-66). The Norwegian Mother and Child Cohort Study (MoBa) is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS (contract no. N01-ES-75558), and NIH/NINDS (grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1). The Rhea project was financially supported by European projects, and the Greek Ministry of Health (Program of Prevention of Obesity and Neurodevelopmental Disorders in Preschool Children, in Heraklion district, Crete, Greece: 2011-2014; 'Rhea Plus': Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012-2015). The work was also supported by MICINN (MTM2015-68140-R) and Centro Nacional de Genotipado-CEGEN-PRB2-ISCIII. CW received funding from the Fondation de France.
Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study

  • Herrero, Jesús Miguel
  • Vega, Pablo
  • Salve, María
  • Bujanda Fernández de Pierola, Luis
  • Cubiella, Joaquín
BackgroundSymptom based referral criteria for colorectal cancer (CRC) detection are the cornerstone of the strategy to improve prognosis in CRC. In 2017, the National Institute for Health and Care Excellence (NICE) updated their referral criteria (2017 NG12). Recently, several studies have evaluated the faecal haemoglobin (f-Hb) concentration in this setting. The aim of this study is to evaluate the diagnostic accuracy of the 2017 NG12 referral criteria and to compare them with the CG27 referral criteria, the f-Hb concentration and two f-Hb based prediction model: COLONPREDICT and FAST Score.MethodsThis is a post-hoc diagnostic test study performed within the COLONPREDICT study database (1572 patients, CRC prevalence 13.6%). We assessed symptoms, the 2017 NG12 and CG27 referral criteria and determined the f-Hb before performing a colonoscopy. We compared the discriminatory ability using the area under the curve (AUC) and the sensitivity and specificity at pre-stablished thresholds with the McNemar's test.ResultsThe 2017 NG12 referral criteria discriminatory ability (AUC 0.53; 95% confidence interval- CI 0.49-0.57) was inferior to the CG27 version (AUC 0.59; 95% CI 0.55-0.63; p=0.01), the f-Hb concentration (AUC 0.86; 95% CI 0.84-0-89; p<0.001), the COLONPREDICT Score (AUC 0.92; 95% CI 0.91-0.94; p<0.001) or the FAST Score (AUC 0.87; 95% CI 0.85-0.89; p<0.001). The number of patients meeting each criteria were as follows: 2017 NG12 and CG27=94.1% and 52.2%; f-Hb 20 and10g/g faeces=38.6 and 44.3%; COLONPREDICT Score5.6 and3.2=29.4 and 63.2% and FAST Score4.50 and2.12=37.1 and 87.0%. The 2017 NG12 criteria were more sensitive (100%) than the CG27 criteria (68.2%), the f-Hb (20g/g) (91.2%), the f-Hb (10g/g) (93.5%), the COLONPREDICT Score (5.6) (90.1%) and the FAST Score (4.50) (89.8%) (p0.001) and equivalent to the COLONPREDICT Score (3.5) (99.5%) or the FAST Score (2.12) (100.0%) (p=1). However, their specificity (6.8%) was significantly lower than any of the evaluated criteria (50.3%, 69.6%, 63.4%, 78.7%, 45.8%, 71.3%, 13.9%; p<0.001).ConclusionReferral criteria based on f-Hb measurement, either as a single test or within prediction models, are more accurate than symptom-based referral criteria for CRC detection in symptomatic patients., This study was supported by a grant from Instituto de Salud Carlos III, Madrid, Spain (PI11/00094). Instituto de Salud Carlos III had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. JC has received an intensification grant through the European Commission funded "BIOCAPS" project (FP-7-REGPOT 2012-2013-1, Grant agreement no. FP7-316265).
Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

  • Cubiella, Joaquín
  • Vega, Pablo
  • Salve, María
  • Díaz Ondina, Marta
  • Alves, Maria Teresa
  • Quintero, Enrique
  • Álvarez Sánchez, Victoria
  • Fernández Bañares, Fernando
  • Boadas, Jaume
  • Campo, Rafel
  • Bujanda Fernández de Pierola, Luis
  • Clofent, Joan
  • Ferrández, Ángel
  • Torrealba, Leyanira
  • Piñol, Virginia
  • Rodríguez Alcalde, Daniel
  • Hernández, Vicent
  • Fernández Seara, Javier
  • COLONPREDICT study investigators
Background: Risk prediction models for colorectal cancer (CRC) detection in symptomatic patients based on available biomarkers may improve CRC diagnosis. Our aim was to develop, compare with the NICE referral criteria and externally validate a CRC prediction model, COLONPREDICT, based on clinical and laboratory variables. Methods: This prospective cross-sectional study included consecutive patients with gastrointestinal symptoms referred for colonoscopy between March 2012 and September 2013 in a derivation cohort and between March 2014 and March 2015 in a validation cohort. In the derivation cohort, we assessed symptoms and the NICE referral criteria, and determined levels of faecal haemoglobin and calprotectin, blood haemoglobin, and serum carcinoembryonic antigen before performing an anorectal examination and a colonoscopy. A multivariate logistic regression analysis was used to develop the model with diagnostic accuracy with CRC detection as the main outcome. Results: We included 1572 patients in the derivation cohort and 1481 in the validation cohorts, with a 13.6 % and 9. 1 % CRC prevalence respectively. The final prediction model included 11 variables: age (years) (odds ratio [OR] 1.04, 95 % confidence interval [CI] 1.02-1.06), male gender (OR 2.2, 95 % CI 1.5-3.4), faecal haemoglobin >= 20 mu g/g (OR 17.0, 95 % CI 10.0-28.6), blood haemoglobin <10 g/dL (OR 4.8, 95 % CI 2.2-10.3), blood haemoglobin 10-12 g/dL (OR 1.8, 95 % CI 1.1-3.0), carcinoembryonic antigen >= 3 ng/mL (OR 4.5, 95 % CI 3.0-6.8), acetylsalicylic acid treatment (OR 0.4, 95 % CI 0.2-0.7), previous colonoscopy (OR 0.1, 95 % CI 0.06-0.2), rectal mass (OR 14.8, 95 % CI 5.3-41.0), benign anorectal lesion (OR 0.3, 95 % CI 0.2-0.4), rectal bleeding (OR 2.2, 95 % CI 1.4-3.4) and change in bowel habit (OR 1.7, 95 % CI 1.1-2.5). The area under the curve (AUC) was 0.92 (95 % CI 0.91-0.94), higher than the NICE referral criteria (AUC 0.59, 95 % CI 0.55-0.63; p < 0.001). On the basis of the thresholds with 90 % (5.6) and 99 % (3.5) sensitivity, we divided the derivation cohort into three risk groups for CRC detection: high (30.9 % of the cohort, positive predictive value [PPV] 40.7 %, 95 % CI 36.7-45.9 %), intermediate (29.5 %, PPV 4.4 %, 95 % CI 2.8-6.8 %) and low (39.5 %, PPV 0.2 %, 95 % CI 0.0-1.1 %). The discriminatory ability was equivalent in the validation cohort (AUC 0.92, 95 % CI 0.90-0.94; p = 0.7). Conclusions: COLONPREDICT is a highly accurate prediction model for CRC detection., This study was funded by a grant from Instituto de Salud Carlos III (PI11/00094). JC and VH have received an intensification grant through the European Commission funded "BIOCAPS" project (FP-7-REGPOT 2012-2013-1, Grant agreement no. FP7-316265). The validation cohort recruitment was funded by a grant from Fundacio de la Marato TV3 2012 (785/U/2013). The funding institutions had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Tesis doctoral (DoctoralThesis)

Estudios de biocompatibilidad y respuesta inmunitaria frente a nanopartículas óxido metálicas

  • Lozano Fernández, Tamara
Nanopartícula (Np) se define como aquella partícula de tamaño entre 1 y 100 nm en al menos dos de sus dimensiones. (Hussain, S.M., et al. Adv. Materials., 2009. 21:1549-1559). Las Nanopartículas presentan unas propiedades físico-químicas específicas, que no exhiben los mismos materiales cuando son utilizados a mayor escala. (Arruebo, M., M. Valladares, and Á. González-Fernández. Journal of Nanomaterials, 2009. 24 pages). Dentro de estas propiedades destacan su mayor área superficial en comparación con otras partículas o materiales, y su mayor reactividad superficial, debido a la capacidad de catalizar reacciones, así como la de absorber y transportar otros compuestos. (Borm, P.J. and W. Kreyling. J Nanosci Nanotechnol, 2004. 4(5): 521-31).Todo ello en conjunto permite la llamada funcionalización de las Nps, que se realiza añadiendo a la Np recubrimientos con sondas, drogas o bioconjugados como ADN, proteínas, polisacáridos o anticuerpos monoclonales, permitiendo así dirigir las Nps hacia elementos específicos. (Arruebo, M., M. Valladares, and Á. González-Fernández. Journal of Nanomaterials, 2009. 24 pages). Estas propiedades de las Nps permiten su utilización en múltiples aspectos de la Biomedicina, diversos productos comerciales y Medioambiente. En este sentido, las Nps presentan un enorme potencial para la mejora de la calidad y aprovechamiento de múltiples productos de consumo público y cotidiano, como la optimización de dispositivos electrónicos, el reforzamiento de materiales, desarrollo de biosensores, etc. (Velev O. D. et al., Adv. Materials, 2009. 21:1897-1905). En cualquier caso, es en el sector de la Biomedicina donde se espera que el uso de nanopartículas suponga una gran revolución, abriendo un extenso abanico de posibilidades en cuanto a su aprovechamiento. Así, una nueva disciplina llamada “Nanomedicina” ha surgido recientemente, que ha sido definida como “el uso de las aplicaciones de la nanotecnología para el tratamiento, diagnóstico, monitorización y control de sistemas biológicos”. (Sanvicens N., M.P.,Trends in Biotechnology, 2008. 26(8): 425-433.:Moghimi, S.M et al. FASEB J, 2005. 19(3):311-30). En este ámbito, una de las principales y más prometedoras aplicaciones de las Nps es la terapia. En este sentido, ya se están probando Nps para el transporte y la liberación de fármacos, en la destrucción de células tumorales mediante mecanismos de hipertermia y en el desarrollo de vacunas. (Gwinn, M.R. and V. Vallyathan,. Environ. Health Persp., 2006. 114(12): 1818-1825). Otra de las posibles aplicaciones de las Nps se encuentra en el diagnóstico de cáncer y otras enfermedades de tipo neurológico y cardiovascular. Estas aplicaciones conllevarían un importante esfuerzo en la investigación para la obtención de imágenes de alta resolución, así como del desarrollo de nuevas modalidades de agentes de contraste que permitan utilizar métodos no invasivos. (Pan, D., et al., Eur J Radiol, 2009. 70(2):274-85)., Nanopartícula (Np) defínese como aquela partícula de tamaño entre 1 e 100 nm en polo menos dous das súas dimensións. (Hussain, S.M., et ao. Adv. Materials., 2009. 21:1549-1559). As Nanopartículas presentan unhas propiedades físico-químicas específicas, que non exhiben os mesmos materiais cando son utilizados a maior escala. (Arruebo, M., M. Valladares, and Á. González-Fernández. Journal of Nanomaterials, 2009. 24 pages). Dentro destas propiedades destacan a súa maior área superficial en comparación con outras partículas ou materiais, e a súa maior reactividade superficial, debido á capacidade de catalizar reaccións, así como a de absorber e transportar outros compostos. (Borm, P.J. and W. Kreyling. J Nanosci. Nanotechnol, 2004. 4(5): 521-31). Todo iso en conxunto permite a chamada funcionalización das Nps, que se realiza engadindo á Np recubrimientos con sondas, drogas ou bioconxugados como ADN, proteínas, polisacáridos ou anticorpos monoclonais, permitindo así dirixir as Nps cara a elementos específicos. (Arruebo, M., M. Valladares, and Á. González-Fernández. Journal of Nanomaterials, 2009. 24 pages). Estas propiedades das Nps permiten a súa utilización en múltiples aspectos da Biomedicina, diversos produtos comerciais e Medio. Neste sentido, as Nps presentan un enorme potencial para a mellora da calidade e aproveitamento de múltiples produtos de consumo público e cotián, como a optimización de dispositivos electrónicos, o reforzamento de materiais, desenvolvemento de biosensores, etc. (Velev Ou. D. et ao., Adv. Materials, 2009. 21:1897-1905). En calquera caso, é no sector da Biomedicina onde se espera que o uso de nanopartículas supoña unha gran revolución, abrindo un extenso abanico de posibilidades en canto ao seu aproveitamento. Así, unha nova disciplina chamada “Nanomedicina” xurdiu recentemente, que pode ser definida como “o uso das aplicacións da nanotecnoloxía para o tratamento, diagnóstico, monitorización e control de sistemas biolóxicos”. (Sanvicens N., M.P.,Trends in Biotechnology, 2008. 26(8): 425-433.:Moghimi, S.M et ao. FASEB J, 2005. 19(3):311-30). Neste ámbito, unha das principais e máis prometedoras aplicacións das Nps é a terapia. Neste sentido, xa se están probando Nps para o transporte e a liberación de fármacos, na destrución de células tumorais mediante mecanismos de hipertermia e no desenvolvemento de vacinas. (Gwinn, M.R. and V. Vallyathan,. Environ. Health Persp., 2006. 114(12): 1818-1825). Outra das posibles aplicacións das Nps atópase no diagnóstico de cancro e outras enfermidades de tipo neurolóxico e cardiovascular. Estas aplicacións levarían un importante esforzo na investigación para a obtención de imaxes de alta resolución, así como do desenvolvemento de novas modalidades de axentes de contraste que permitan utilizar métodos non invasivos. (Pan, D., et ao., Eur J Radiol, 2009. 70(2):274-85)., Xunta de Galicia
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Improving the text classification using clustering and a novel HMM to reduce the dimensionality

  • Seara Vieira, Adrián
  • Borrajo Diz, Maria Lourdes
  • Lorenzo Iglesias, Eva Maria
In text classification problems, the representation of a document has a strong impact on the performance of learning systems. The high dimensionality of the classical structured representations can lead to burdensome computations due to the great size of real-world data. Consequently, there is a need for reducing the quantity of handled information to improve the classification process. In this paper, we propose a method to reduce the dimensionality of a classical text representation based on a clustering technique to group documents, and a previously developed Hidden Markov Model to represent them. We have applied tests with the k-NN and SVM classifiers on the OHSUMED and TREC benchmark text corpora using the proposed dimensionality reduction technique. The experimental results obtained are very satisfactory compared to commonly used techniques like InfoGain and the statistical tests performed demonstrate the suitability of the proposed technique for the preprocessing step in a text classification task., Universidade de Vigo | Ref. 12VI08
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

PVM/MA-shelled selol nanocapsules promote cell cycle arrest in A549 lung adenocarcinoma cells

  • Souza, Ludmilla Regina de
  • Muehlmann, Luis Alexandre
  • Santos, Mayara Simonelly Costa dos
  • Ganassin, Rayane
  • Simón Vázquez, Rosana
  • Anselmo Joanitti, Graziella
  • Mosiniewicz-Szablewska, Ewa
  • Suchocki, Piotr
  • Morais, Paulo Cesar
  • González Fernández, Maria Africa
  • Azevedo, Ricardo Bentes
  • Bao, Sônia Nair
Background Selol is an oily mixture of selenitetriacylglycerides that was obtained as a semi-synthetic compound containing selenite. Selol is effective against cancerous cells and less toxic to normal cells compared with inorganic forms of selenite. However, Selol’s hydrophobicity hinders its administration in vivo. Therefore, the present study aimed to produce a formulation of Selol nanocapsules (SPN) and to test its effectiveness against pulmonary adenocarcinoma cells (A549). Results Nanocapsules were produced through an interfacial nanoprecipitation method. The polymer shell was composed of poly(methyl vinyl ether-co-maleic anhydride) (PVM/MA) copolymer. The obtained nanocapsules were monodisperse and stable. Both free Selol (S) and SPN reduced the viability of A549 cells, whereas S induced a greater reduction in non-tumor cell viability than SPN. The suppressor effect of SPN was primarily associated to the G2/M arrest of the cell cycle, as was corroborated by the down-regulations of the CCNB1 and CDC25C genes. Apoptosis and necrosis were induced by Selol in a discrete percentage of A549 cells. SPN also increased the production of reactive oxygen species, leading to oxidative cellular damage and to the overexpression of the GPX1, CYP1A1, BAX and BCL2 genes. Conclusions This study presents a stable formulation of PVM/MA-shelled Selol nanocapsules and provides the first demonstration that Selol promotes G2/M arrest in cancerous cells., Xunta de Galicia
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

MAHMI database: a comprehensive MetaHit-based resource for the study of the mechanism of action of the human microbiota

  • Blanco Míguez, Aitor
  • Gutiérrez Jácome, Alberto
  • Fernández Riverola, Florentino
  • GARCIA LOURENÇO, Analia Maria
  • Sanchez Garcia, Borja
The Mechanism of Action of the Human Microbiome (MAHMI) database is a unique resource that provides comprehensive information about the sequence of potential immunomodulatory and antiproliferative peptides encrypted in the proteins produced by the human gut microbiota. Currently, MAHMI database contains over 300 hundred million peptide entries, with detailed information about peptide sequence, sources and potential bioactivity. The reference peptide data section is curated manually by domain experts. The in silico peptide data section is populated automatically through the systematic processing of publicly available exoproteomes of the human microbiome. Bioactivity prediction is based on the global alignment of the automatically processed peptides with experimentally validated immunomodulatory and antiproliferative peptides, in the reference section. MAHMI provides researchers with a comparative tool for inspecting the potential immunomodulatory or antiproliferative bioactivity of new amino acidic sequences and identifying promising peptides to be further investigated. Moreover, researchers are welcome to submit new experimental evidence on peptide bioactivity, namely, empiric and structural data, as a proactive, expert means to keep the database updated and improve the implemented bioactivity prediction method. Bioactive peptides identified by MAHMI have a huge biotechnological potential, including the manipulation of aberrant immune responses and the design of new functional ingredients/foods based on the genetic sequences of the human microbiome. Hopefully, the resources provided by MAHMI will be useful to those researching gastrointestinal disorders of autoimmune and inflammatory nature, such as Inflammatory Bowel Diseases. MAHMI database is routinely updated and is available free of charge., Ministerio de Economía y Competitividad | Ref. AGL2013-44039-R, Xunta de Galicia | Ref. EM2014/046
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

An HMM-based text classifier less sensitive to document management problems

  • Seara Vieira, Adrián
  • Lorenzo Iglesias, Eva Maria
  • Borrajo Diz, Maria Lourdes
Background: The performance of the text classification techniques is commonly affected by the characteristics and representation of the document corpora itself. Of all the problems arising from the corpus, there are three major difficulties which the classifiers must deal with: the feature selection issues, the class imbalance problem and the size of the training set. Objective: The objective of this paper is to present a novel based-content text classifier called T-LHMM that is less sensitive to the text representation and the size of the corpus, and more efficient in terms of running time than other classification techniques. Method: In order to demonstrate it, we present a set of experiments performed on well-known biomedical text corpora. We also compare our classifier with k-Nearest Neighbours and Support Vector Machine models. Results and Conclusion: The experimental and statistical results show that the proposed HMM-based text classifier is indeed less sensitive to the class imbalance, the size of the corpus and the vocabulary than the other classifiers. In addition, it is more efficient in terms of running time than k-NN and SVM techniques., Ministerio de Economía y Competitividad | Ref. TIN2013-47153-C3-3-R
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

A sensitivity analysis comparison of three models for the dynamics of germinal centers

  • Faro Rivas, Jose Manuel
  • von Haeften, Bernardo
  • Gardner, Rui
  • Faro Rivas, Emilio
Germinal centers (GCs) are transient anatomical microenvironments where antibody affinity maturation and memory B cells generation takes place. In the past, models of Germinal Center (GC) dynamics have focused on understanding antibody affinity maturation rather than on the main mechanism(s) driving their rise-and-fall dynamics. Here, based on a population dynamics model core, we compare three mechanisms potentially responsible for this GC biphasic behavior dependent on follicular dendritic cell (FDC) maturation, follicular T helper (Tfh) cell maturation, and antigen depletion. Analyzing the kinetics of B and T cells, as well as its parameter sensitivities, we found that only the FDC-maturation-based model could describe realistic GC dynamics, whereas the simple Tfh-maturation and antigen-depletion mechanisms, as implemented here, could not. We also found that in all models the processes directly related to Tfh cell kinetics have the highest impact on GC dynamics. This suggests the existence of some still unknown mechanism(s) tuning GC dynamics by affecting Tfh cell response to proliferation-inducing stimuli., Fundação para Ciência e Tecnologia | Ref. POCTI/36413/1999, Xunta de Galicia | Ref. ED431C 2016041
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Ion channels and thermosensitivity: TRP, TREK, or both?

  • Lamas Castro, José Antonio
  • Rueda Ruzafa, Lola
  • Herrera Pérez, Salvador
Controlling body temperature is a matter of life or death for most animals, and in mammals the complex thermoregulatory system is comprised of thermoreceptors, thermosensors, and effectors. The activity of thermoreceptors and thermoeffectors has been studied for many years, yet only recently have we begun to obtain a clear picture of the thermosensors and the molecular mechanisms involved in thermosensory reception. An important step in this direction was the discovery of the thermosensitive transient receptor potential (TRP) cationic channels, some of which are activated by increases in temperature and others by a drop in temperature, potentially converting the cells in which they are expressed into heat and cold receptors. More recently, the TWIK-related potassium (TREK) channels were seen to be strongly activated by increases in temperature. Hence, in this review we want to assess the hypothesis that both these groups of channels can collaborate, possibly along with other channels, to generate the wide range of thermal sensations that the nervous system is capable of handling., Ministerio de Economía y Competitividadd | Ref. BFU2014-58999-P, Xunta de Galicia | Ref. GPC2015-022
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

A quantitative binding study of fibrinogen and human serum albumin to metal oxide nanoparticles by surface plasmon resonance

  • Canoa Román, Pilar
  • Simón Vázquez, Rosana
  • Popplewell, Jonathan
  • González Fernández, Maria Africa
The interaction of plasma proteins with metal oxide nanoparticles (NPs) is important due to the potential biomedical application of these NPs. In this study, new approaches were applied to measure quantitatively the kinetics and affinities of fibrinogen and human serum albumin (HSA) for TiO2, CeO2, Al2O3 and ZnO NPs immobilized on a sensor chip. Real-time surface plasmon resonance (SPR) measurements showed that fibrinogen interacted with TiO2 and CeO2 NPs with high affinity (135 and 40 pM, respectively) and to Al2O3 NPs with moderate affinity (15 nM). The data fitted well to the Langmuir model describing a 1:1 interaction. In contrast, HSA interacted with TiO2, CeO2 and Al2O3 NPs with lower affinity (80 nM, 37 nM and 2 µM, respectively) with the data fitting better to the conformational change model. TiO2 and CeO2 NPs had fast association rate constants with fibrinogen (1×106 M−1 s−1) and Al2O3 NPs had a slower association rate constant (1×104 M−1 s−1). By contrast, HSA had markedly slower association rate constants (1×103–1×104 M−1 s−1). The binding of the proteins was reversible, thus allowing the rapid capture of data for replicates. The occurrence of matrix effects was evaluated by using surfaces with different chemistries to capture the NPs, namely alginate, NeutrAvidin and bare gold. The affinity values determined for the NP–protein interactions were largely independent of the underlying surface used to capture the NPs., Xunta de Galicia | Ref. GPC2013-005
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons

  • Fernández Fernández, Diego
  • Cadaveira Mosquera, Alba
  • Rueda Ruzafa, Lola
  • Herrera Pérez, Salvador
  • Veale, Emma L
  • Reboreda Prieto, Antonio
  • Mathie, Alistair
  • Lamas Castro, José Antonio
Two-pore domain potassium channels (K2P) constitute major candidates for the regulation of background potassium currents in mammalian cells. Channels of the TREK subfamily are also well positioned to play an important role in sensory transduction due to their sensitivity to a large number of physiological and physical stimuli (pH, mechanical, temperature). Following our previous report describing the molecular expression of different K2P channels in the vagal sensory system, here we confirm that TREK channels are functionally expressed in neurons from the mouse nodose ganglion (mNG). Neurons were subdivided into three groups (A, Ah and C) based on their response to tetrodotoxin and capsaicin. Application of the TREK subfamily activator riluzole to isolated mNG neurons evoked a concentration-dependent outward current in the majority of cells from all the three subtypes studied. Riluzole increased membrane conductance and hyperpolarized the membrane potential by approximately 10 mV when applied to resting neurons. The resting potential was similar in all three groups, but C cells were clearly less excitable and showed smaller hyperpolarization-activated currents at -100 mV and smaller sustained currents at -30 mV. Our results indicate that the TREK subfamily of K2P channels might play an important role in the maintenance of the resting membrane potential in sensory neurons of the autonomic nervous system, suggesting its participation in the modulation of vagal reflexes., Ministerio de Economía y Competitividad | Ref. BFU2014-58999-P, Xunta de Galicia | Ref. GPC2015/022
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

An HMM-based over-sampling technique to improve text classification

  • Lorenzo Iglesias, Eva Maria
  • Seara Vieira, Adrián
  • Borrajo Diz, Maria Lourdes
This paper presents a novel over-sampling method based on document content to handle the class imbalance problem in text classification. The new technique, COS-HMM (Content-based Over-Sampling HMM), includes an HMM that is trained with a corpus in order to create new samples according to current documents. The HMM is treated as a document generator which can produce synthetical instances formed on what it was trained with. To demonstrate its achievement, COS-HMM is tested with a Support Vector Machine (SVM) in two medical documental corpora (OHSUMED and TREC Genomics), and is then compared with the Random Over-Sampling (ROS) and SMOTE techniques. Results suggest that the application of over-sampling strategies increases the global performance of the SVM to classify documents. Based on the empirical and statistical studies, the new method clearly outperforms the baseline method (ROS), and offers a greater performance than SMOTE in the majority of tested cases.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Conformational changes in human plasma proteins induced by metal oxide nanoparticles

  • Simón Vázquez, Rosana
  • Lozano Fernández, Tamara
  • Peleteiro Olmedo, Mercedes
  • González Fernández, Maria Africa
The interaction of nanoparticles (Nps) with body fluids may induce conformational changes in the proteins present in the medium. Such interactions could induce functional loss or important modifications in some proteins, and trigger cellular events induced by the Np-protein moiety. As metal oxide nanoparticles are widely used for various applications, the interaction of four different metal oxide Nps (ZnO, TiO2, CeO2 and Al2O3) with three of the main protein fractions from human plasma (albumin, fibrinogen and globulins) was characterized by fluorescence and Fourier-transform infrared (FTIR) spectroscopy. The pattern of Np–protein interaction was shown to vary depending on the type of Np. For ZnO Nps, a strong interaction was observed, which induced a decrease in the thermal stability of both fibrinogen and albumin at a low temperature, interfering with the clotting activity of fibrinogen. TiO2 and CeO2 Nps showed lower effects, while for Al2O3 Nps only a slight or null interaction was observed at physiological pH. Moreover, the influence of pH was characterized for albumin, showing that the Np–protein interaction has an important dependence on the Np surface charge. The conformational changes induced by metal oxide Nps in the secondary structure of albumin are principally the transformation of α-helices into β-sheet structures. The interaction, with the exception of Al2O3 nanoparticles at basic pH, could take place in the domain II of the protein, formed mainly by hydrophobic and positive residues.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

An HMM-based synthetic view generator to improve the efficiency of ensemble systems

  • Borrajo Diz, Maria Lourdes
  • Seara Vieira, Adrián
  • Lorenzo Iglesias, Eva Maria
One of the most active areas of research in semi-supervised learning has been to study methods for constructing good ensembles of classifiers. Ensemble systems are techniques that create multiple models and then combine them to produce improved results. These systems usually produce more accurate solutions than a single model would. Specially, multi-view ensemble systems improve the accuracy of text classification because they optimize the functions to exploit different views of the same input data. However, despite being more promising than the single-view approaches, document datasets often have no natural multiple views available. This study proposes an algorithm to generate a synthetic view from a standard text dataset. The model generates a new view from the standard bag-of-words approach using an algorithm based on hidden Markov models (HMMs). To show the effectiveness of the proposed HMM-based synthetic view generation method, it has been integrated in a co-training ensemble system and tested with four text corpora: Reuters, 20 Newsgroup, TREC Genomics and OHSUMED. The results obtained are promising, showing a significant increase in the efficiency of the ensemble system compared to a single-view approach., Ministerio de Economía y Competitividad | Ref. TIN2013-47153-C3-3-R, Universidade de Vigo | Ref. 14VI05
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Tesis doctoral (DoctoralThesis)

Evaluación de la respuesta inmunitaria inducida por nanovacunas poliméricas

  • Peleteiro Olmedo, Mercedes
La vacunación es una de las intervenciones más exitosas y coste-efectivas de la salud pública y que tiene un extraordinario impacto en la sociedad. Sin embargo, es un proceso que, lamentablemente, está restringido principalmente a los países industrializados, existiendo una gran disparidad en su accesibilidad entre los países industrializados y los países en vías de desarrollo. El fracaso a la hora de dar cobertura en materia de inmunización a los países en vías de desarrollo se atribuye fundamentalmente a tres problemas (Friede et al, 2005, Adv. Drug Delivery Rev., 57:325). El primero es la cadena del frío. La mayoría de las vacunas deben ser conservadas y enviadas dentro de un rango de temperatura para que conserve toda su eficacia, y las infraestructuras de muchos países no aseguran la cadena del frío de las vacunas durante su conservación y distribución. La rotura en la cadena del frío, lleva a la pérdida irreversible del antígeno y por tanto a la pérdida de eficacia de la vacuna. Por otro lado, la vía de administración habitual de las vacunas requiere el empleo de jeringas, cuyo uso conlleva, en los países en vías de desarrollo, un altísimo riesgo de infección (principalmente hepatitis y sida) debido a la reutilización de las agujas y a su indebida eliminación. Por último, para inducir una completa respuesta inmune protectora frente a las enfermedades infecciosas mediante la vacunación, es necesario un esquema de vacunación en varias dosis y espaciadas en el tiempo. El abandono o no seguimiento correcto de las pautas de vacunación, llevan a una reducción de la eficacia vacunal. La nanomedicina ofrece, al día de hoy, una de las estrategias más valiosas para resolver los problemas asociados a la vacunación y, por ello, de gran incidencia en la salud global. Las diferentes aproximaciones a la nanomedicina utilizadas para resolver los problemas citados son: • La nanomedicina y el desarrollo de vacunas mono-dosis: La aplicación de los microsistemas de liberación controlada para el desarrollo de vacunas monodosis ha sido una iniciativa de la OMS con el fin de ampliar la cobertura de inmunización frente a determinadas enfermedades infecciosas tales como el tétanos y la difteria. Estudios previos han dado a conocer el potencial de microesferas constituidas por un núcleo estabilizante (gelatina y aceite) recubierto por una película de poli(ácido láctico/ácido glicólico) (PLGA), así como las micromatrices consistentes en mezclas PLGA y poloxameros, que tienen una gran capacidad para inducir respuesta inmune frente al toxoide tetánico prolongadas y muy superiores a las conseguidas tras la administración de antígeno adsorbido en aluminio (vacuna comercial) (Sánchez et al, 1999, Int J Pharm., 185:255; Schwendeman SP et al.,1996, Dev. Biol. Stand, 87:293; Tobio et al., 1998, Pharm Res., 15: 270; Tobio et al., 1999, Vaccine, 12:618; Tobio et al., 1999, Pharm Res, 16:682). La limitación de estos sistemas es su tamaño y su dificultad para ser inyectada. Además la eficacia de estos sistemas para la administración de vacunas virales no ha podido ser demostrada, lo que sugiere la necesidad de una adecuación de las tecnologías y estructuras resultantes en función de las características de las vacunas. En esta línea, y fruto del trabajo coordinado de los grupos del Dr. Langer, la Dra. Alonso y la Dra. González (solicitantes de este proyecto) y financiado por la Fundación Gates, existe información preliminar que revela el interesante potencial de nanoestructuras constituidas a partir de polisacáridos y lípidos., A vacinación é unha das intervencións máis exitosas e custo-efectivas da saúde pública e que ten un extraordinario impacto na sociedade. Con todo, é un proceso que, lamentablemente, está restrinxido principalmente aos países industrializados, existindo unha gran disparidade na súa accesibilidade entre os países industrializados e os países en vías de desenvolvemento. O fracaso á hora de dar cobertura en materia de inmunización aos países en vías de desenvolvemento atribúese fundamentalmente a tres problemas (Friede et al, 2005, Adv. Drug Delivery Rev., 57:325). O primeiro é a cadea do frío. A maioría das vacinas deben ser conservadas e enviadas dentro dun rango de temperatura para que conserve toda a súa eficacia, e as infraestruturas de moitos países non aseguran a cadea do frío das vacinas durante a súa conservación e distribución. A rotura na cadea do frío, leva á perda irreversible do antíxeno e polo tanto á perda de eficacia da vacina. Doutra banda, a vía de administración habitual das vacinas require o emprego de xiringas, cuxo uso leva, nos países en vías de desenvolvemento, un altísimo risco de infección (principalmente hepatite e sida) debido á reutilización das agullas e á súa indebida eliminación. Para rematar, para inducir unha completa resposta inmune protectora fronte ás enfermidades infecciosas mediante a vacinación, é necesario un esquema de vacinación en varias doses e espaciadas no tempo. O abandono ou non seguimento correcto das pautas de vacinación, levan a unha redución da eficacia vacunal. A nanomedicina ofrece, ao día de hoxe, unha das estratexias máis valiosas para resolver os problemas asociados á vacinación e, por iso, de gran incidencia na saúde global. As diferentes aproximacións á nanomedicina utilizadas para resolver os problemas citados son: • A nanomedicina e o desenvolvemento de vacinas mono-dose: A aplicación dos microsistemas de liberación controlada para o desenvolvemento de vacinas monodosis foi unha iniciativa da OMS co fin de ampliar a cobertura de inmunización fronte a determinadas enfermidades infecciosas tales como o tétanos e a difteria. Estudos previos deron a coñecer o potencial de microesferas constituídas por un núcleo estabilizante (gelatina e aceite) recuberto por unha película de poli(acedo láctico/acedo glicólico) (PLGA), así como as micromatrices consistentes en mesturas de PLGA e poloxameros, que teñen unha gran capacidade para inducir resposta inmunitaria fronte ao toxoide tetánico prolongadas e moi superiores ás conseguidas tras a administración de antíxeno adsorbido en aluminio (vacina comercial) (Sánchez et al, 1999, Int J Pharm., 185:255; Schwendeman SP et al.,1996, Dev. Biol. Caseta, 87:293; Tobio et al., 1998, Pharm Res., 15: 270; Tobio et al., 1999, Vaccine, 12:618; Tobio et al., 1999, Pharm Res, 16:682). A limitación destes sistemas é o seu tamaño e a súa dificultade para ser inxectada. Ademais a eficacia destes sistemas para a administración de vacinas virales non puido ser demostrada, o que suxire a necesidade dunha adecuación das tecnoloxías e estruturas resultantes en función das características das vacinas. Nesta liña, e froito do traballo coordinado dos grupos do Dr. Langer, a Dra. Alonso e a Dra. González (solicitantes deste proxecto) e financiado pola Fundación Gates, existe información preliminar que revela o interesante potencial de nanoestructuras constituídas a partir de polisacáridos e lípidos., Ministerio de Sanidad y Consumo | Ref. PI080751, Ministerio de Economía y Competitividad | Ref. SAF2011-30337-C02-02
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Systemic treatment of Fabry disease using a novel AAV9 vector expressing α-galactosidase A

  • Biferi, Maria Grazia
  • Cohen Tannoudji, Mathilde
  • García Silva, Andrea
  • Souto Rodríguez, Olga
  • Viéitez González, Irene
  • San Millán Tejado, Beatriz
  • Fernandez Carrera, Andrea
  • Pérez Márquez, Tania
  • Teijeira Bautista, Susana
  • Barrera, Soraya
  • Dominguez Lorenzo, Vanesa
  • Marais, Thibaut
  • González Fernández, Maria Africa
  • Barkats, Martine
  • Ortolano, Saida
Fabry disease is a rare X-linked disorder affecting α-galactosidase A, a rate-limiting enzyme in lysosomal catabolism of glycosphingolipids. Current treatments present important limitations, such as low half-life and limited distribution, which gene therapy can overcome. The aim of this work was to test a novel adeno-associated viral vector, serotype 9 (AAV9), ubiquitously expressing human α-galactosidase A to treat Fabry disease (scAAV9-PGK-GLA). The vector was preliminary tested in newborns of a Fabry disease mouse model. 5 months after treatment, α-galactosidase A activity was detectable in the analyzed tissues, including the central nervous system. Moreover, we tested the vector in adult animals of both sexes at two doses and disease stages (presymptomatic and symptomatic) by single intravenous injection. We found that the exogenous α-galactosidase A was active in peripheral tissues as well as the central nervous system and prevented glycosphingolipid accumulation in treated animals up to 5 months following injection. Antibodies against α-galactosidase A were produced in 9 out of 32 treated animals, although enzyme activity in tissues was not significantly affected. These results demonstrate that scAAV9-PGK-GLA can drive widespread and sustained expression of α-galactosidase A, cross the blood brain barrier after systemic delivery, and reduce pathological signs of the Fabry disease mouse model, Association Vaincre Les Maladies Lysosomales | Ref. AO2017-3, Ministerio de Ciencia e Innovación | Ref. PI11/00842, Instituto de Salud Carlos III | Ref. PI19/01886, Ministerio de Ciencia e Innovación | Ref. PEJ2018-005289-A
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Tesis doctoral (DoctoralThesis)

Application of data mining and artificial intelligence techniques to mass spectrometry data for knowledege discovery

  • López Fernández, Hugo
Mass spectrometry using matrix assisted laser desorption ionization coupled to time of flight analyzers (MALDI-TOF MS) has become popular during the last decade due to its high speed, sensitivity and robustness for detecting proteins and peptides. This allows quickly analyzing large sets of samples are in one single batch and doing high-throughput proteomics. In this scenario, bioinformatics methods and computational tools play a key role in MALDI-TOF data analysis, as they are able handle the large amounts of raw data generated in order to extract new knowledge and useful conclusions. A typical MALDI-TOF MS data analysis workflow has three main stages: data acquisition, preprocessing and analysis. Although the most popular use of this technology is to identify proteins through their peptides, analyses that make use of artificial intelligence (AI), machine learning (ML), and statistical methods can be also carried out in order to perform biomarker discovery, automatic diagnosis, and knowledge discovery. In this research work, this workflow is deeply explored and new solutions based on the application of AI, ML, and statistical methods are proposed. In addition, an integrated software platform that supports the full MALDI-TOF MS data analysis workflow that facilitate the work of proteomics researchers without advanced bioinformatics skills has been developed and released to the scientific community., Ministerio de Ciencia e Innovación | Ref. TIN2009-14057-C03-02, Ministerio de Ciencia e Innovación | Ref. AIB2010PT-00353, Universidade de Vigo | Ref. 15VI013, Universidade de Vigo | Ref. 08VIB6, Concello de Ourense | Ref. INOU-14-08
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Metal oxide nanoparticles interact with immune cells and activate different cellular responses

  • Simón Vázquez, Rosana
  • Lozano Fernández, Tamara
  • Dávila Grana, Ángela
  • González Fernández, Maria Africa
Besides cell death, nanoparticles (Nps) can induce other cellular responses such as inflammation. The potential immune response mediated by the exposure of human lymphoid cells to metal oxide Nps (moNps) was characterized using four different moNps (CeO2, TiO2, Al2O3, and ZnO) to study the three most relevant mitogen-activated protein kinase subfamilies and the nuclear factor kappa-light-chain-enhancer of the activated B-cell inhibitor, IκBα, as well as the expression of several genes by immune cells incubated with these Nps. The moNps activated different signaling pathways and altered the gene expression in human lymphocyte cells. The ZnO Nps were the most active and the release of Zn2+ ions was the main mechanism of toxicity. CeO2 Nps induced the smallest changes in gene expression and in the IκBα protein. The effects of the particles were strongly dependent on the type and concentration of the Nps and on the cell activation status prior to Np exposure., Xunta de Galicia | Ref. GPC2013-005
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Structural characterization of bioceramics and mineralized tissues based on Raman and XRD techniques

  • Leite Da Silva Aguiar, Helio
  • Chiussi , Stefano
  • López Álvarez, Miriam
  • González Fernández, Pío Manuel
  • Serra Rodríguez, Julia Asunción
The design of new bioceramics requires a deep understanding of their structural characteristics using a combination of different characterization techniques. This paper offers an exhaustive Raman spectroscopy and X-ray diffraction study of two groups of bioceramics natural and synthetic, as well as of living tissues with different degrees of mineralization. Based on these results, two Raman-XRD correlation charts are proposed. Using a single Raman measurement, these charts are valuable tools for the identification of a number of structural parameters, such as the apatite phase percentage or crystallite size, of different calcium phosphate-based bioceramics and mineralized tissues., Xunta de Galicia-FEDER | Ref. GRC2013-008 and R2014/033, European Commission| Ref. FP7/REGPOT- 2012–2013.1, n.316265 BIOCAPS
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

T follicular helper and T follicular regulatory cells have different TCR specificity

  • Maceiras, Ana Raquel
  • Almeida, Silvia Cristina Paiva
  • Mariotti Ferrandiz, Encarnita
  • Chaara, Wahiba
  • Jebbawi, Fadi
  • Six, Adrien
  • Hori, Shohei
  • Klatzmann, David
  • Faro Rivas, Jose Manuel
  • Graca, Luis
Immunization leads to the formation of germinal centres (GCs) that contain both T follicular helper (Tfh) and T follicular regulatory (Tfr) cells. Whether T-cell receptor (TCR) specificity defines the differential functions of Tfh and Tfr cells is unclear. Here we show that antigenspecific T cells after immunization are preferentially recruited to the GC to become Tfh cells, but not Tfr cells. Tfh cells, but not Tfr cells, also proliferate efficiently on restimulation with the same immunizing antigen in vitro. Ex vivo TCR repertoire analysis shows that immunization induces oligoclonal expansion of Tfh cells. By contrast, the Tfr pool has a TCR repertoire that more closely resembles that of regulatory T (Treg) cells. Our data thus indicate that the GC Tfh and Tfr pools are generated from distinct TCR repertoires, with Tfh cells expressing antigen-responsive TCRs to promote antibody responses, and Tfr cells expressing potentially autoreactive TCRs to suppress autoimmunity., Fundação para Ciência e Tecnologia | Ref. PTDC/SAU-IMU/120225/2010, Fundação para Ciência e Tecnologia | Ref. HMSP-ICT/0034/2013, Fundação para Ciência e Tecnologia | Ref. FCT-FAPESP/19906/2014, Fundação para Ciência e Tecnologia | Ref. SFRH/BD/88030/2012, Fundação para Ciência e Tecnologia | Ref. SFRH/BDP/81391/2011, European Commission | Ref. PIRSES-GA-2012-317893 (INDOEUROPEAN-MATHDS), European Commission | Ref. REGPOT-2012-2013.1-316265 (BIOCAPS)
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)

  • Narváez García, Francisco Javier
  • EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology)
The aim of the study was to profile those patients included in the RELESSER registry with histologically proven renal involvement in order to better understand the current state of lupus nephritis (LN) in Spain. RELESSER-TRANS is a multicenter cross-sectional registry with an analytical component. Information was collected from the medical records of patients with systemic lupus erythematosus who were followed at participating rheumatology units. A total of 359 variables including demographic data, clinical manifestations, disease activity, severity, comorbidities, LN outcome, treatments, and mortality were recorded. Only patients with a histological confirmation of LN were included. We performed a descriptive analysis, chi-square or Student's t tests according to the type of variable and its relationship with LN. Odds ratio and confidence intervals were calculated by using simple logistic regression. LN was histologically confirmed in 1092/3575 patients (30.5%). Most patients were female (85.7%), Caucasian (90.2%), and the mean age at LN diagnosis was 28.4 +/- 12.7 years. The risk for LN development was higher in men (M/F: 47.85/30.91%, P < 0.001), in younger individuals (P < 0.001), and in Hispanics (P = 0.03). Complete response to treatment was achieved in 68.3% of patients; 10.35% developed ESRD, which required a kidney transplant in 45% of such cases. The older the patient, the greater was the likelihood of complete response (P < 0.001). Recurrences were associated with persistent lupus activity at the time of the last visit (P < 0.001) and with ESRD (P < 0.001). Thrombotic microangiopathy was a risk factor for ESRD (P = 0.04), as for the necessity of dialysis (P = 0.01) or renal transplantation (P = 0.03). LN itself was a poor prognostic risk factor of mortality (OR 2.4 [1.81-3.22], P < 0.001). Patients receiving antimalarials had a significantly lower risk of developing LN (P < 0.001) and ESRD (P < 0.001), and responded better to specific treatments for LN (P = 0.014). More than two-thirds of the patients with LN from a wide European cohort achieved a complete response to treatment. The presence of positive anti-Sm antibodies was associated with a higher frequency of LN and a decreased rate of complete response to treatment. The use of antimalarials reduced both the risk of developing renal disease and its severity, and contributed to attaining a complete renal response.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

  • Cubiella, Joaquín
  • Vega, Pablo
  • Salve, María
  • Díaz-Ondina, Marta
  • Alves, Maria Teresa
  • Quintero, Enrique
  • Álvarez-Sánchez, Victoria
  • Fernández Bañares, Fernando
  • Boadas, Jaume
  • Campo Fernández de los Rios, Rafael
  • Bujanda, Luis
  • Clofent, Juan
  • Ferrandez, Ángel
  • Torrealba, Leyanira
  • Piñol Sánchez, Virgínia
  • Rodríguez-Alcalde, Daniel
  • Hernández, Vicent
  • Fernández-Seara, Javier
  • Ribes Puig, Josepa
  • COLONPREDICT study investigators
Background: risk prediction models for colorectal cancer (CRC) detection in symptomatic patients based on available biomarkers may improve CRC diagnosis. Our aim was to develop, compare with the NICE referral criteria and externally validate a CRC prediction model, COLONPREDICT, based on clinical and laboratory variables. Methods: this prospective cross-sectional study included consecutive patients with gastrointestinal symptoms referred for colonoscopy between March 2012 and September 2013 in a derivation cohort and between March 2014 and March 2015 in a validation cohort. In the derivation cohort, we assessed symptoms and the NICE referral criteria, and determined levels of faecal haemoglobin and calprotectin, blood haemoglobin, and serum carcinoembryonic antigen before performing an anorectal examination and a colonoscopy. A multivariate logistic regression analysis was used to develop the model with diagnostic accuracy with CRC detection as the main outcome. Results: we included 1572 patients in the derivation cohort and 1481 in the validation cohorts, with a 13.6 % and 9.1 % CRC prevalence respectively. The final prediction model included 11 variables: age (years) (odds ratio [OR] 1.04, 95 % confidence interval [CI] 1.02-1.06), male gender (OR 2.2, 95 % CI 1.5-3.4), faecal haemoglobin ≥20 μg/g (OR 17.0, 95 % CI 10.0-28.6), blood haemoglobin <10 g/dL (OR 4.8, 95 % CI 2.2-10.3), blood haemoglobin 10-12 g/dL (OR 1.8, 95 % CI 1.1-3.0), carcinoembryonic antigen ≥3 ng/mL (OR 4.5, 95 % CI 3.0-6.8), acetylsalicylic acid treatment (OR 0.4, 95 % CI 0.2-0.7), previous colonoscopy (OR 0.1, 95 % CI 0.06-0.2), rectal mass (OR 14.8, 95 % CI 5.3-41.0), benign anorectal lesion (OR 0.3, 95 % CI 0.2-0.4), rectal bleeding (OR 2.2, 95 % CI 1.4-3.4) and change in bowel habit (OR 1.7, 95 % CI 1.1-2.5). The area under the curve (AUC) was 0.92 (95 % CI 0.91-0.94), higher than the NICE referral criteria (AUC 0.59, 95 % CI 0.55-0.63; p < 0.001). On the basis of the thresholds with 90 % (5.6) and 99 % (3.5) sensitivity, we divided the derivation cohort into three risk groups for CRC detection: high (30.9 % of the cohort, positive predictive value [PPV] 40.7 %, 95 % CI 36.7-45.9 %), intermediate (29.5 %, PPV 4.4 %, 95 % CI 2.8-6.8 %) and low (39.5 %, PPV 0.2 %, 95 % CI 0.0-1.1 %). The discriminatory ability was equivalent in the validation cohort (AUC 0.92, 95 % CI 0.90-0.94; p = 0.7). Conclusions: COLONPREDICT is a highly accurate prediction model for CRC detection.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A peptidome-based phylogeny pipeline reveals differential peptides at the strain level within Bifidobacterium animalis subsp. lactis

  • Blanco-Míguez, Aitor
  • Gutiérrez-Jácome, Alberto
  • Fdez-Riverola, Florentino
  • Lourenço, Anália
  • Sánchez García, Borja
Bifidobacteria are gut commensal microorganisms belonging to the Actinobacteria group. Some specific strains of Bifidobacterium animalis subsp. lactis are used in functional foods as they are able to exert health-promoting effects in the human host. Due to the limited genetic variability within this subspecies, it is sometimes difficult for a manufacturer to properly track its strain once included in dairy products or functional foods. In this paper, we present a peptidome-based analysis in which the proteomes of a set of B. animalis subsp. lactis strains were digested in silico with human gut endopeptidases. The molecular masses were compared along all the strains to detect strain-specific peptides. These peptides may be interesting towards the development of methodologies for strain identification in the final product., This research was funded by Grant AGL2013-44039-R from the Spanish “Plan Estatal de I+D+I”, and by Grant EM2014/046 from the “Plan Galego de investigación, innovación e crecemento 2011–2015”. Borja Sánchez was recipient of a Ramón y Cajal postdoctoral contract from the Spanish Ministry of Economy and Competitiveness (RYC-2012-10052). This work was also partially funded by the [14VI05] Contract-Programme from the Unixikversity of Vigo and the Agrupamento INBIOMED from DXPCTSUG-FEDER unha maneira de facer Europa (2012/273). The research leading to these results has also received funding from the European Union’s Seventh Framework ProgrammeFP7/REGPOT-2012-2013.1 under grant agreement no 316265, BIOCAPS. This document reflects only the author’s views and the European Union is not liable for any use that may be made of the information contained herein., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Improving phylogeny reconstruction at the strain level using peptidome datasets

  • Blanco-Míguez, Aitor
  • Meier-Kolthoff, Jan P.
  • Gutiérrez-Jácome, Alberto
  • Göker, M.
  • Fdez-Riverola, Florentino
  • Sánchez García, Borja
  • Lourenço, Anália
Typical bacterial strain differentiation methods are often challenged by high genetic similarity between strains. To address this problem, we introduce a novel in silico peptide fingerprinting method based on conventional wet-lab protocols that enables the identification of potential strain-specific peptides. These can be further investigated using in vitro approaches, laying a foundation for the development of biomarker detection and application-specific methods. This novel method aims at reducing large amounts of comparative peptide data to binary matrices while maintaining a high phylogenetic resolution. The underlying case study concerns the Bacillus cereus group, namely the differentiation of Bacillus thuringiensis, Bacillus anthracis and Bacillus cereus strains. Results show that trees based on cytoplasmic and extracellular peptidomes are only marginally in conflict with those based on whole proteomes, as inferred by the established Genome-BLAST Distance Phylogeny (GBDP) method. Hence, these results indicate that the two approaches can most likely be used complementarily even in other organismal groups. The obtained results confirm previous reports about the misclassification of many strains within the B. cereus group. Moreover, our method was able to separate the B. anthracis strains with high resolution, similarly to the GBDP results as benchmarked via Bayesian inference and both Maximum Likelihood and Maximum Parsimony. In addition to the presented phylogenomic applications, whole-peptide fingerprinting might also become a valuable complementary technique to digital DNA-DNA hybridization, notably for bacterial classification at the species and subspecies level in the future., This research was funded by Grant AGL2013-44039-R from the Spanish “Plan Estatal de I+D+I”, and by Grant EM2014/046 from the “Plan Galego de investigación, innovación e crecemento 2011-2015”. BS was recipient of a Ramón y Cajal postdoctoral contract from the Spanish Ministry of Economy and Competitiveness. This work was also partially funded by the [14VI05] Contract-Programme from the University of Vigo and the Agrupamento INBIOMED from DXPCTSUG-FEDER unha maneira de facer Europa (2012/273). The research leading to these results has also received funding from the European Union's Seventh Framework Programme FP7/REGPOT-2012-2013.1 under grant agreement n° 316265, BIOCAPS, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Engineering microencapsulation of highly catalytic gold nanoclusters for an extreme thermal stability

  • Sousa-Castillo, Ana
  • Gauthier, Sébastien
  • Arenal, Raúl
  • Pérez-Lorenzo, Moisés
  • Correa-Duarte, Miguel A.
A synthetic strategy for the microencapsulation of ultra-small gold nanoparticles toward the development of a novel nanoreactor is reported. In this case, it is shown that the catalytic activity of Au nanoclusters as small as 0.8 nm remains unaffected after a thermal treatment up to 800 °C in air. This is accomplished through the deposition and further coating of the gold nanoparticles in a void/silica/Au/silica configuration where the nature of the alternate shells can be tuned regardless of each other's porosity and the size of the embedded metal nanoparticles. Such spatial confinement suppresses the growth of the gold nanoclusters and thus preserves their catalytic properties. In this way, a remarkable compromise between the immobilization and the accessibility to the metal nanocatalyst can be met. Furthermore, these nanoreactors are found to be colloidally stable in simulated body fluids which also makes them suitable for biomedical applications. The implementation of hollow nanoreactors containing highly dispersed and immobilized but accessible ultra-small metal nanoparticles constitutes a promising alternative in the search for model catalysts stable under realistic technical conditions., This work was funded by Xunta de Galicia (INBIOMED-FEDER “unha maneira de facer Europa” and EM2014/035), Fundación Ramón Areces, Fundación Tatiana Pérez de Guzmán el Bueno, and European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1] under Grant Agreement no. 316265, BIOCAPS. The scanning transmission electron microscopy (STEM) studies were conducted at Laboratorio de Microscopías Avanzadas (LMA) at Instituto de Nanociencia de Aragón (INA) – Universidad de Zaragoza (Spain). The STEM measurements were supported by the European Union Seventh Framework Program under Grant Agreement 312483-ESTEEM2 (Integrated Infrastructure Initiative-I3). R. A. acknowledges funding from MINECO-Spain (FIS2013-46159-C3-3-P) and EU-H2020 project ITN-Enabling Excellence (Grant number 642742)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hierarchical nanoplatforms for high-performance enzyme biocatalysis under denaturing conditions

  • González-Domínguez, Elena
  • Arenal, Raúl
  • Pérez-Lorenzo, Moisés
  • Correa-Duarte, Miguel A.
et al., A hierarchically structured nanoplatform comprising the integration of enzymes into a hybrid carbon-nanotube-based magnetic nanocomposite was developed. By means of this complex support, laccases are endowed with exceptional performance even in fully denaturing environments. In this regard, up to 10-fold enhancements in the biocatalytic activity of the enzymes can be attained at different temperatures and pH conditions. Furthermore, these platforms are found to provide laccases with unprecedented recycling potential. In this line, these composites allow straightforward recovery and reuse of the biocatalysts with no loss of efficiency even after 10 successive runs. These outstanding operational capabilities make these nanocarriers a promising material to tackle the challenges associated with the implementation of enzymes in industrial biotechnology., This work was funded by Xunta de Galicia (INBIOMED-FEDER “unha maneira de facer Europa”, EM2014/035, and EM2014/041), MINECO-Spain (CTM2014-58481-R), Fundación Ramón Areces, Fundación Tatiana Pérez de Guzmán el Bueno, and European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1] under Grant Agreement no. 316265, BIOCAPS. The scanning transmission electron microscopy (STEM) and aberration-corrected TEM studies were conducted at Laboratorio de Microscopías Avanzadas (LMA) at Instituto de Nanociencia de Aragón (INA)—Universidad de Zaragoza (Spain). The STEM measurements were supported by European Union Seventh Framework Program under Grant Agreement 312483-ESTEEM2 (Integrated Infrastructure Initiative-I3). R.A. acknowledges funding from MINECO-Spain (FIS2013-46159-C3-3-P) and EU-H2020 project ITN-Enabling Excellence (Grant Number 642742)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia

  • Bujanda, L.
  • Sarasqueta, C.
  • Vega, P.
  • Salve, M.
  • Quintero, E.
  • Alvarez-Sánchez, V.
  • Fernández-Bañares, F.
  • Boadas, J.
  • Campo, R.
  • Garayoa, A.
  • Ferrandez, A.
  • Torrealba, L.
  • Rodríguez-Alcaide, D.
  • D’Amato, M.
  • Hernández, V.
  • Cubiella, J.
Background: Aspirin (ASA) is a drug that can cause gastrointestinal lesions and symptoms. Colorectal cancer (CRC) is the most prevalent type of cancer in Western countries. We assessed the effect of aspirin on the diagnostic accuracy of the faecal immunochemical test (FIT) for CRC and/or advanced neoplasia (AN) in patients undergoing colonoscopy for gastrointestinal symptoms. Methods: We conducted a prospective multicentre observational study of diagnostic tests that included patients with gastrointestinal symptoms undergoing colonoscopy between March 2012 and 2014 (the COLONPREDICT study). Symptoms were assessed and a FIT and blood tests assessing haemoglobin and carcinoembryonic antigen (CEA) levels were performed. Results: The study included 3052 patients: A total of 2567 did not take aspirin (non-user group) and 485 (16%) took aspirin (user group). Continuous treatment with ASA did not change the AUC (0.88, 0.82; p = 0.06), sensitivity (92%, 88%; p = 0.5) or specificity (71%, 67%; p = 0.2) of the FIT for CRC detection. Similarly, we found no differences in the AUC (0.81, 0.79; p = 0.6), sensitivity (74%, 75.5%; p = 0.3) or specificity (76%, 73.6%; p = 0.3) for AN detection. Patients with an aspirin use of = 300 mg/day had a lower prevalence of AN and the sensitivity, specificity and AUC for AN for these patients were 54%, 68% and 0.66, significantly lower than for the non-user group (p = 0.03). Conclusions: Aspirin does not modify the diagnostic accuracy of FIT for CRC and/or AN in patients with gastrointestinal symptoms. Aspirin use of = 300 mg/day decreases the accuracy of the test.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

  • Torrente-Segarra, V.
  • Salman-Monte, T.C.
  • Rúa-Figueroa, Í.
  • del Campo, V.
  • López-Longo, F.J.
  • Galindo-Izquierdo, M.
  • Calvo-Alén, J.
  • Olivé-Marqués, A.
  • Mouriño-Rodríguez, C.
  • Horcada, L.
  • Bohórquez, C.
  • Montilla, C.
  • Salgado, E.
  • Díez-Álvarez, E.
  • Blanco, R.
  • Andreu, J.L.
  • Fernández-Berrizbeitia, O.
  • Expósito, L.
  • Gantes, M.
  • Hernández-Cruz, B.
  • Pecondón-Español, Á.
  • Lozano-Rivas, N.
  • Bonilla, G.
  • Lois Iglesias, A.
  • Rubio-Muñoz, P.
  • Ovalles, J.
  • Tomero, E.
  • Boteanu, A.
  • Narvaez, J.
  • Freire, M.
  • Vela, P.
  • Quevedo-Vila, V.
  • Juan Mas, A.
  • Muñoz-Fernández, S.
  • Raya, E.
  • Moreno, M.
  • Velloso-Feijoo, M.L.
  • Soler, G.
  • Vázquez-Rodríguez, T.R.
  • Pego-Reigosa, J.M.
Objective: To assess the incidence of serious infection (SI) and associated factors in a large juvenile-onset systemic lupus erythematosus (jSLE) retrospective cohort. Methods: All patients in the Spanish Rheumatology Society Lupus Registry (RELESSER) who meet =4 ACR-97 SLE criteria and disease onset <18 years old (jSLE), were retrospectively investigated for SI (defined as either the need for hospitalization with antibacterial therapy for a potentially fatal infection or death caused by the infection). Standardized SI rate was calculated per 100 patient years. Patients with and without SI were compared. Bivariate and multivariate logistic and Cox regression models were built to calculate associated factors to SI and relative risks. Results: A total of 353 jSLE patients were included: 88.7% female, 14.3 years (± 2.9) of age at diagnosis, 16.0 years (± 9.3) of disease duration and 31.5 years (±10.5) at end of follow-up. A total of 104 (29.5%) patients suffered 205 SI (1, 55.8%; 2-5, 38.4%; and =6, 5.8%). Incidence rate was 3.7 (95%CI: 3.2–4.2) SI per 100 patient years. Respiratory location and bacterial infections were the most frequent. Higher number of SLE classification criteria, SLICC/ACR DI score and immunosuppressants use were associated to the presence of SI. Associated factors to shorter time to first infection were higher number of SLE criteria, splenectomy and immunosuppressants use. Conclusions: The risk of SI in jSLE patients is significant and higher than aSLE. It is associated to higher number of SLE criteria, damage accrual, some immunosuppressants and splenectomy.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)

  • Narváez García, Francisco Javier
  • EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology)
The aim of the study was to profile those patients included in the RELESSER registry with histologically proven renal involvement in order to better understand the current state of lupus nephritis (LN) in Spain. RELESSER-TRANS is a multicenter cross-sectional registry with an analytical component. Information was collected from the medical records of patients with systemic lupus erythematosus who were followed at participating rheumatology units. A total of 359 variables including demographic data, clinical manifestations, disease activity, severity, comorbidities, LN outcome, treatments, and mortality were recorded. Only patients with a histological confirmation of LN were included. We performed a descriptive analysis, chi-square or Student's t tests according to the type of variable and its relationship with LN. Odds ratio and confidence intervals were calculated by using simple logistic regression. LN was histologically confirmed in 1092/3575 patients (30.5%). Most patients were female (85.7%), Caucasian (90.2%), and the mean age at LN diagnosis was 28.4 +/- 12.7 years. The risk for LN development was higher in men (M/F: 47.85/30.91%, P < 0.001), in younger individuals (P < 0.001), and in Hispanics (P = 0.03). Complete response to treatment was achieved in 68.3% of patients; 10.35% developed ESRD, which required a kidney transplant in 45% of such cases. The older the patient, the greater was the likelihood of complete response (P < 0.001). Recurrences were associated with persistent lupus activity at the time of the last visit (P < 0.001) and with ESRD (P < 0.001). Thrombotic microangiopathy was a risk factor for ESRD (P = 0.04), as for the necessity of dialysis (P = 0.01) or renal transplantation (P = 0.03). LN itself was a poor prognostic risk factor of mortality (OR 2.4 [1.81-3.22], P < 0.001). Patients receiving antimalarials had a significantly lower risk of developing LN (P < 0.001) and ESRD (P < 0.001), and responded better to specific treatments for LN (P = 0.014). More than two-thirds of the patients with LN from a wide European cohort achieved a complete response to treatment. The presence of positive anti-Sm antibodies was associated with a higher frequency of LN and a decreased rate of complete response to treatment. The use of antimalarials reduced both the risk of developing renal disease and its severity, and contributed to attaining a complete renal response.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

  • Cubiella, Joaquín
  • Vega, Pablo
  • Salve, María
  • Díaz-Ondina, Marta
  • Alves, Maria Teresa
  • Quintero, Enrique
  • Álvarez-Sánchez, Victoria
  • Fernández Bañares, Fernando
  • Boadas, Jaume
  • Campo Fernández de los Rios, Rafael
  • Bujanda, Luis
  • Clofent, Juan
  • Ferrandez, Ángel
  • Torrealba, Leyanira
  • Piñol Sánchez, Virgínia
  • Rodríguez-Alcalde, Daniel
  • Hernández, Vicent
  • Fernández-Seara, Javier
  • Ribes Puig, Josepa
  • COLONPREDICT study investigators
Background: risk prediction models for colorectal cancer (CRC) detection in symptomatic patients based on available biomarkers may improve CRC diagnosis. Our aim was to develop, compare with the NICE referral criteria and externally validate a CRC prediction model, COLONPREDICT, based on clinical and laboratory variables. Methods: this prospective cross-sectional study included consecutive patients with gastrointestinal symptoms referred for colonoscopy between March 2012 and September 2013 in a derivation cohort and between March 2014 and March 2015 in a validation cohort. In the derivation cohort, we assessed symptoms and the NICE referral criteria, and determined levels of faecal haemoglobin and calprotectin, blood haemoglobin, and serum carcinoembryonic antigen before performing an anorectal examination and a colonoscopy. A multivariate logistic regression analysis was used to develop the model with diagnostic accuracy with CRC detection as the main outcome. Results: we included 1572 patients in the derivation cohort and 1481 in the validation cohorts, with a 13.6 % and 9.1 % CRC prevalence respectively. The final prediction model included 11 variables: age (years) (odds ratio [OR] 1.04, 95 % confidence interval [CI] 1.02-1.06), male gender (OR 2.2, 95 % CI 1.5-3.4), faecal haemoglobin ≥20 μg/g (OR 17.0, 95 % CI 10.0-28.6), blood haemoglobin <10 g/dL (OR 4.8, 95 % CI 2.2-10.3), blood haemoglobin 10-12 g/dL (OR 1.8, 95 % CI 1.1-3.0), carcinoembryonic antigen ≥3 ng/mL (OR 4.5, 95 % CI 3.0-6.8), acetylsalicylic acid treatment (OR 0.4, 95 % CI 0.2-0.7), previous colonoscopy (OR 0.1, 95 % CI 0.06-0.2), rectal mass (OR 14.8, 95 % CI 5.3-41.0), benign anorectal lesion (OR 0.3, 95 % CI 0.2-0.4), rectal bleeding (OR 2.2, 95 % CI 1.4-3.4) and change in bowel habit (OR 1.7, 95 % CI 1.1-2.5). The area under the curve (AUC) was 0.92 (95 % CI 0.91-0.94), higher than the NICE referral criteria (AUC 0.59, 95 % CI 0.55-0.63; p < 0.001). On the basis of the thresholds with 90 % (5.6) and 99 % (3.5) sensitivity, we divided the derivation cohort into three risk groups for CRC detection: high (30.9 % of the cohort, positive predictive value [PPV] 40.7 %, 95 % CI 36.7-45.9 %), intermediate (29.5 %, PPV 4.4 %, 95 % CI 2.8-6.8 %) and low (39.5 %, PPV 0.2 %, 95 % CI 0.0-1.1 %). The discriminatory ability was equivalent in the validation cohort (AUC 0.92, 95 % CI 0.90-0.94; p = 0.7). Conclusions: COLONPREDICT is a highly accurate prediction model for CRC detection.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comprehensive description of clinical characteristics of a large systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences

  • Rua Figueroa, Íñigo|||0000-0002-7894-1690
  • Richi, Patricia
  • López Longo, Francisco Javier
  • Galindo, María|||0000-0002-7264-2577
  • Calvo Alén, Jaime|||0000-0001-9378-8412
  • Olivé Marqués, Alejandro|||0000-0002-6707-8043
  • Loza-Santamaría, Estíbaliz
  • Pérez Vicente, Sabina
  • Erausquin-Arruabarrena, Celia
  • Tomero, Eva
  • Horcada-Rubio, Loreto
  • Uriarte-Isacelaya, Esther
  • Sánchez-Atrio, Ana
  • Rosas, José|||0000-0002-3916-6046
  • Montilla, Carlos
  • Fernández-Nebro, Antonio|||0000-0002-2962-9844
  • Rodríguez-Gómez, Manuel
  • Vela, Paloma|||0000-0001-8566-5172
  • Blanco, Ricardo|||0000-0003-2344-2285
  • Freire, Mercedes
  • Silva, Lucía
  • Díez-Álvarez, Elvira
  • Ibáñez-Barceló, Mónica
  • Zea, Antonio
  • Narváez García, Francisco Javier
  • Martínez-Taboada, Víctor
  • Marenco, José Luis
  • Fernández de Castro, Mónica
  • Fernández-Berrizbeitia, Olaia
  • Hernández-Beriain, José Ángel
  • Gantes, Marian
  • Hernández-Cruz, Blanca|||0000-0001-6423-3610
  • Pérez-Venegas, José J.
  • Pecondón, Ángela
  • Marras, Carlos|||0000-0002-7791-9889
  • Carreira, Patricia E.|||0000-0001-8279-3806
  • Bonilla, Gema
  • Torrente, Vicente
  • Castellvi, Ivan|||0000-0002-5410-5807
  • Alegre Allué, Juan Luis
  • Moreno Martínez-Losa, Mireia|||0000-0002-4365-4341
  • Raya, Enrique
  • García de la Peña, Paloma|||0000-0001-6586-6903
  • Vázquez, Tomás
  • Aguirre, Ángeles
  • Quevedo, Víctor
  • Pego-Reigosa, José M.
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ involvement and pronounced racial and ethnic heterogeneity. The aims of the present work were (1) to describe the cumulative clinical characteristics of those patients included in the Spanish Rheumatology Society SLE Registry (RELESSER), focusing on the differences between patients who fulfilled the 1997 ACR-SLE criteria versus those with less than 4 criteria (hereafter designated as incomplete SLE (iSLE)) and (2) to compare SLE patient characteristics with those documented in other multicentric SLE registries. RELESSER is a multicenter hospital-based registry, with a collection of data from a large, representative sample of adult patients with SLE (1997 ACR criteria) seen at Spanish rheumatology departments. The registry includes demographic data, comprehensive descriptions of clinical manifestations, as well as information about disease activity and severity, cumulative damage, comorbidities, treatments and mortality, using variables with highly standardized definitions. A total of 4.024 SLE patients (91% with ≥4 ACR criteria) were included. Ninety percent were women with a mean age at diagnosis of 35.4 years and a median duration of disease of 11.0 years. As expected, most SLE manifestations were more frequent in SLE patients than in iSLE ones and every one of the ACR criteria was also associated with SLE condition; this was particularly true of malar rash, oral ulcers and renal disorder. The analysis-adjusted by gender, age at diagnosis, and disease duration-revealed that higher disease activity, damage and SLE severity index are associated with SLE [OR: 1.14; 95% CI: 1.08-1.20 (P < 0.001); 1.29; 95% CI: 1.15-1.44 (P < 0.001); and 2.10; 95% CI: 1.83-2.42 (P < 0.001), respectively]. These results support the hypothesis that iSLE behaves as a relative stable and mild disease. SLE patients from the RELESSER register do not appear to differ substantially from other Caucasian populations and although activity [median SELENA-SLEDA: 2 (IQ: 0-4)], damage [median SLICC/ACR/DI: 1 (IQ: 0-2)], and severity [median KATZ index: 2 (IQ: 1-3)] scores were low, 1 of every 4 deaths was due to SLE activity. RELESSER represents the largest European SLE registry established to date, providing comprehensive, reliable and updated information on SLE in the southern European population.